ShockWave Medical, Inc.
SWAV · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $1 | $0 | $0 | $0 |
| % Growth | 49.1% | 106.5% | 249.8% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 86.9% | 86.7% | 82.5% | 69% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | $0 | $0 | -$0 | -$0 |
| % Margin | 22.7% | 25.3% | -0.4% | -96.9% |
| Other Income/Exp. Net | $0 | -$0 | -$0 | $0 |
| Pre-Tax Income | $0 | $0 | -$0 | -$0 |
| Tax Expense | $0 | -$0 | $0 | $0 |
| Net Income | $0 | $0 | -$0 | -$0 |
| % Margin | 20.2% | 44.1% | -3.9% | -96.9% |
| EPS | 4.01 | 6.02 | -0.26 | -1.99 |
| % Growth | -33.4% | 2,415.4% | 86.9% | – |
| EPS Diluted | 3.85 | 5.7 | -0.26 | -1.99 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | -$0 | -$0 | $0 |
| EBITDA | $0 | $0 | -$0 | -$0 |
| % Margin | 26.1% | 26% | -0.4% | -93.2% |